Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Merck Patent describes IRAK inhibitors

Aug. 25, 2016

Chiesi develops compounds with mAChR antagonistic and beta2-adrenoceptor agonist activity

Aug. 25, 2016

F. Hoffmann-La Roche discloses HBsAg inhibitors

Aug. 25, 2016

Basilea Pharmaceutica patents MAPK inhibitors

Aug. 25, 2016

FORMA Therapeutics describes HDAC inhibitors

Aug. 24, 2016

FORMA Therapeutics patents HDAC 6 inhibitors

Aug. 23, 2016

Sanford-Burnham Medical Research Institute reports glucocorticoid receptor translocation inhibitors

Aug. 23, 2016

Novo Nordisk divulges neuropeptide Y receptor agonists

Aug. 23, 2016

Trillium Therapeutics patents EGFR inhibitors

Aug. 23, 2016

FORMA Therapeutics discloses ubiquitin hydrolase inhibitors

Aug. 23, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...